pharmaceutical investing Rexahn Pharmaceuticals Presents Preliminary Safety and Efficacy Data From Ongoing Phase 2a Clinical Trial
pharmaceutical investing Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin) in combination with KEYTRUDA (pembrolizumab) for Triple Negative Breast Cancer
Rio Silver Provides Shareholders With a Five-Step Plan to Access High-Grade Surface Silver and Advance Toward Near-Term Production at Maria Norte
CoTec Holdings Corp. Notes Portfolio Company Magiron Completes Independent Definitive Feasibility Study Confirming Strong Economics and Rapid Restart Pathway
